Faculty Publications

Fayad L, Patel H, Verhoef G, Smith MR, Johnson PW, Czuczman MS, Coiffier B, Hess G, Gine E, Advani A, Offner F, Vandendries ER, Shapiro M, Dang NH

Safety and Clinical Activity of the Anti-CD22 Immunoconjugate Inotuzumab Ozogamicin (CMC-544) in Combination with Rituximab in Follicular Lymphoma or Diffuse Large B-Cell Lymphoma: Preliminary Report of a Phase 1/2 Study

2008;:105.

Abstract